Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria
Publication Date
Publication Journal
Author(s)
Leah Rankine-Wilson, Tirosh Shapira, Jake Felker, Matthew Christofferson, Henok Sahile, Joseph Chao, Houria Afshar, Raymond J. Andersen, Jim Sun, and Yossef Av-Gay
Upon infection with Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis, macrophage immune cells trap it within a membrane bubble known as a phagosome and acidify the interior of the bubble to kill the bacterium. In this study, the authors treated Mtb-infected macrophages with an inhibitor of phagosome acidification and found that, even while blocking acid-induced death, the compound killed the bacterium. This work reveals a complex role for phagosome acidification in pathogenesis and points toward new avenues for host-directed therapies against mycobacterial infections.